TruAlt Bioenergy Ltd Q1 FY27 Earnings Analysis

Published 31 May 2026 | Agricultural Food & other Products | Market Cap: ₹4.2K Cr

Price

495

Market Cap

₹4.2K Cr

P/E Ratio

28.6

Revenue Rank

Rank 2

Margin Rank

Rank 3

Earnings Summary

- TruAlt Bioenergy aims to achieve a minimum of 40 crore litres ethanol sales volume, with a bonus target of 55 crore litres (Page 23). - TruAlt Bioenergy aims to achieve at least 40 crore litres ethanol sales volume by FY27, with a bonus target of 55 crore litres, reflecting strong volume growth potential.

📊 Revenue & Sales Performance

Rank 2

- TruAlt Bioenergy aims to achieve a minimum of 40 crore litres ethanol sales volume, with a bonus target of 55 crore litres (Page 23). - Current ethanol sales run rate is 2.2 crore litres/month; expected increase to about 5 crore litres/month once additional 15 crore litres supply from OMCs is implemented (Page 5). - Revenue run rate target from ethanol is around INR 350-400 crores per month if 6 crore litres capacity is utilized (Page 27). - Execution of 15 crore litres additional ethanol order is pending government/OMC approval, expected after 24-30 months (FY29) (Page 29). - Exploration of export opportunities and sustainable aviation fuel plans to diversify revenue streams and improve capacity utilization (Pages 5, 23, 29). - Compressed Biogas (CBG) business shows strong growth potential with steady 85%+ capacity utilization and EBITDA more than 45%, aiming for phased scaling beyond current 10+4 planned plants (Pages 17, 21). - Fuel retail vertical expected to drive additional revenue growth with 75 planned outlets, seven currently operational showing INR 105 crores revenue from them (Page 18).

📈 Profitability & Margins

Rank 3

- TruAlt Bioenergy aims to achieve at least 40 crore litres ethanol sales volume by FY27, with a bonus target of 55 crore litres, reflecting strong volume growth potential. - Additional revenue streams planned from sustainable aviation fuel and ethanol exports to fully utilize ethanol capacity. - CBG business shows high margin potential with expected EBITDA margins around 50-60%; scalability planned through phased capex after current plants stabilize. - Fuel retail vertical expected to expand significantly with plans for about 75 retail outlets, potentially generating substantial incremental revenue. - Management cautious on timelines; new plant commissioning slated for FY29 (24-30 months out), which will bring one-time income after commissioning. - Despite recent challenges and lower EBITDA growth impacting profits, long-term outlook includes diversified revenue streams and increasing blending mandates driving demand. - Marketing and advertisement spend to increase to support fuel retail business expansion, aiding growth. - Overall, earnings expected to grow with volume ramp-up, policy tailwinds, and diversification beyond government subsidies.

🏗️ Capital Expenditure Plans

Yes

- TruAlt Bioenergy plans to commission a new plant expected within 24 to 30 months (FY29) for which they will receive a one-shot payment once operational. - They are investing in multiple CBG (Compressed Bio-Gas) plants: 9-10 to be live by current year and 10-15 more planned, funded via a 70:30 debt-to-equity mix. - Funding includes 51% investment from TruAlt and 49% from JV partners Sumitomo and GAIL, with NABARD loans at favorable interest rates (around 8.65%). - A fourth CBG plant is planned pending land clearance, aiming for a total of 11 units. - Expansion into fuel retail vertical with plans for up to 75 outlets to drive future revenue growth. - Investments also target diversification into sustainable aviation fuel and export of ethanol to reduce dependence on government policy.

💰 Fundraising & Capital Structure

Yes

- TruAlt Bioenergy plans to fund the expansion of their CBG plants through a mix of debt and equity. - The company will invest 51% equity, while JV partners Sumitomo and GAIL will contribute 49%. - Capital has already been provisioned and infused into subsidiaries for this purpose. - Debt financing has been tied up, notably with NABARD at an interest rate of 8.65% for Sumitomo plans. - The debt-to-equity mix targeted for funding is approximately 70% debt and 30% equity. - Management acknowledged the need for more investor engagement on fundraising updates going forward.

📋 Order Book & Pipeline

No

- TruAlt Bioenergy has existing purchase orders (POs) from private OMCs for about 8 crore litres of ethanol, with only 1.6 crore litres supplied so far; balance 6+ crore litres pending lifting due to delay in indent issuance. - A court order dated February 4, 2026, mandates OMCs to lift an additional 15 crore litres within three months; this has not been implemented yet due to ongoing litigation involving LTOA holders and OMCs. - Total expected orderbook for FY 2027 including OMC allocations is approximately 40 crore litres (public + private OMCs) plus pending 15 crore litres from the court order, targeting a peak capacity of around 55 crore litres. - Inventory of nearly INR500 crores is built awaiting order execution. - Implementation of pending orders expected to resume post resolution of related court cases around June to September 2026.

Key Metrics

Revenue

Rank 2

Margin

Rank 3

Capex

Yes

Fundraise

Yes

Order Book

No

Frequently Asked Questions

What were TruAlt Bioenergy Ltd Q1 FY27 results?

- TruAlt Bioenergy aims to achieve a minimum of 40 crore litres ethanol sales volume, with a bonus target of 55 crore litres (Page 23). - TruAlt Bioenergy aims to achieve at least 40 crore litres ethanol sales volume by FY27, with a bonus target of 55 crore litres, reflecting strong volume growth potential.

What is TruAlt Bioenergy Ltd share price analysis?

TruAlt Bioenergy Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 28.6 with a market cap of ₹4,223. Investors should review the full earnings analysis for detailed insights.

Is TruAlt Bioenergy Ltd planning capital expenditure?

- TruAlt Bioenergy plans to commission a new plant expected within 24 to 30 months (FY29) for which they will receive a one-shot payment once operational.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.

Others in Agricultural Food & other Products this season

  • Marico Ltd (Q1 FY27)

    Marico Ltd Q1 FY27 quarterly results analysis. No information is provided regarding the same in the latest conference call. Market Cap ₹109,194, P/E 62.0. AI-po

  • Tata Consumer Products Ltd (Q1 FY27)

    Tata Consumer Products Ltd Q1 FY27 quarterly results analysis. - Tata Consumer Products aims for consistent double-digit top-line growth, with recent quarters s

  • Balrampur Chini Mills Ltd (Q1 FY27)

    Balrampur Chini Mills Ltd Q1 FY27 quarterly results analysis. - The PLA project is a key strategic initiative expected to drive growth with an 80,000 tonnes cap

  • Kaveri Seed Company Ltd (Q1 FY27)

    Kaveri Seed Company Ltd Q1 FY27 quarterly results analysis. - FY27 revenue growth expected between 15% to 20%, primarily driven by volume growth rather than pri